|
Hope, here is a link to a report on a study done by MD Anderson; some of the study patients were able to resume Herceptin with no problem. Hope this helps.
"TORONTO, ON -- September 15, 2004 -- Cardiotoxic events that occur as a result of treatment with the human monoclonal antibody trastuzumab (Herceptin) are largely reversible, according to a study from the MD Anderson Cancer Center, in Houston, Texas"
|